The Scientists and Researchers at Verge Genomics leverage advanced computational biology, drug discovery, and disease modeling techniques to identify and validate new targets for neurodegenerative disease treatments. They employ a multidisciplinary approach, integrating molecular biology, pharmacology, and bioinformatics to accelerate the development and optimization of life-saving therapeutics.
Chao Wang
Principal Scientist
Fatma Ayhan
Associate Principal Computatio...
Géraldine Gontier
Associate Principal Scientist
Kevan Shah
Team Lead, Disease Modeling & ...
Laurin Heinrich
Scientist II
Madhurima Dhara
Associate Principal Scientist
Melanie Cobb
Associate Principal Scientist
Ningzhe Zhang
Principal Scientist
Robert Galemmo
Distinguished Scientist
Srihari Radhakrishna...
Principal Computational Biolog...
View all